I-Mab Cash Conversion Cycle 2011-2026 | IMAB

Annual Cash Conversion Cycle I-Mab

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-1.97 K	15.5	4.65	-	-	-	-	-	-	-	-

All numbers in CNY currency

Maximum	Minimum	Average
15.5	-1.97 K	-649

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	-3.12 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Coherus BioSciences CHRS	149	$ 1.63	-4.4 %	$ 191 M	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
Enlivex Therapeutics Ltd. ENLV	-193	$ 0.73	-0.03 %	$ 33.4 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 7.83	-5.21 %	$ 214 M	Israel
Esperion Therapeutics ESPR	99.7	$ 3.12	-	$ 649 M	USA
Exelixis EXEL	-8.32	$ 51.1	-0.37 %	$ 13.9 B	USA
Karyopharm Therapeutics KPTI	71.2	$ 8.9	0.56 %	$ 1.08 M	USA
AbCellera Biologics ABCL	173	$ 4.4	-7.76 %	$ 1.31 B	Canada
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	205	$ 17.3	-5.57 %	$ 809 M	USA
Compugen Ltd. CGEN	-82.7	$ 3.03	6.32 %	$ 283 M	Israel
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Gilead Sciences GILD	115	$ 132.06	-0.74 %	$ 164 B	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Grifols, S.A. GRFS	0.000171	$ 7.79	1.04 %	$ 5.29 B	Spain
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Fortress Biotech FBIO	-74.9	$ 2.3	3.14 %	$ 64.2 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	158	$ 21.57	-0.55 %	$ 2.74 B	USA
Fennec Pharmaceuticals FENC	148	$ 9.24	36.48 %	$ 264 M	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA